POU5F1 and teratocarcinoma: Considering the clinically relevant link between PHGDH/Oct4 co-expression and patient survival, NT2/D1 teratocarcinoma cells with stem-like features will stimulate further research into the therapeutic utility of PHGDH–Oct4 axis.